SGA
ONC

Seaport Global Advisors’s BeOne Medicines Ltd ONC Stock Holding History

Seaport Global Advisors’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,358
Closed -$244K – 104
2023
Q3 		$244K Buy
1,358
+244
+22% +$48.3K 0.73% 48
2023
Q2 		$199K Sell
1,114
-374
-25% -$86.1K 0.58% 67
2023
Q1 		$321K Sell
1,488
-399
-21% -$95.7K 1.01% 28
2022
Q4 		$415K Buy
1,887
+235
+14% +$43.1K 1.44% 17
2022
Q3 		$223K Sell
1,652
-614
-27% -$105K 0.91% 50
2022
Q2 		$367K Sell
2,266
-191
-8% -$29.8K 1.37% 14
2022
Q1 		$463K Buy
+2,457
New +$522K 1.48% 17

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return

Seaport Global Advisors's ONC Position: Q4 2023 in Review

Seaport Global Advisors sold out of BeOne Medicines Ltd (ONC) in Q4 2023, closing a stake of 1,358 shares — an estimated $244K sold.

Seaport Global Advisors first reported a position in ONC in Q1 2022 and held it in 7 quarters. The position peaked at $463K in Q1 2022. 204 funds tracked by Wall St. Rank hold ONC as of Q4 2023.

  • Seaport Global Advisors reported no remaining BeOne Medicines Ltd position as of Q4 2023 after selling out during the quarter.
  • Seaport Global Advisors sold 1,358 BeOne Medicines Ltd shares in Q4 2023, an estimated $244K.
  • Seaport Global Advisors first reported a position in BeOne Medicines Ltd in Q1 2022 and held it in 7 quarters.
  • Seaport Global Advisors's BeOne Medicines Ltd position peaked at $463K in Q1 2022.
  • 204 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2023.

Based on Seaport Global Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.